Blood Immune Cells as Biomarkers in Long-Term Surviving Patients with Advanced Non-Small-Cell Lung Cancer Undergoing a Combined Immune/Chemotherapy

SIMPLE SUMMARY: Tumor cells can evade recognition and killing via immune cells by expressing co-inhibitory membrane molecules, which suppress the activity of tumor-specific T cells. Immune checkpoint inhibitor (ICI) therapies act by blocking these inhibitory pathways via monoclonal antibodies. Due t...

Descripción completa

Detalles Bibliográficos
Autores principales: Möller, Miriam, Schütte, Wolfgang, Turzer, Steffi, Seliger, Barbara, Riemann, Dagmar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572005/
https://www.ncbi.nlm.nih.gov/pubmed/37835567
http://dx.doi.org/10.3390/cancers15194873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572005/
https://www.ncbi.nlm.nih.gov/pubmed/37835567
http://dx.doi.org/10.3390/cancers15194873

Ejemplares similares